C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update

Name: C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update
SKU: 2940
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 37 No. 4 Articles Tags: c-lindsay-devane, elderly, jacob-mintzer, medworks-media, neuropsychiatric-disorders, psychopharmacology-bulletin, risperidone

Description

C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update

Description

C. Lindsay DeVane, PharmD

GENERAL PSYCHOPHARMACOLOGY

Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update

C. Lindsay DeVane, PharmD, and Jacob Mintzer, MD

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan

C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update

Description

C. Lindsay DeVane, PharmD

GENERAL PSYCHOPHARMACOLOGY

Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update

C. Lindsay DeVane, PharmD, and Jacob Mintzer, MD

Related products

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan